For: | Zhang S, Ma Y. Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanisms. World J Psychiatry 2022; 12(9): 1127-1140 [PMID: 36186499 DOI: 10.5498/wjp.v12.i9.1127] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v12/i9/1127.htm |
Number | Citing Articles |
1 |
Dutta Rajib. Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature. Journal of Neuroscience and Neurological Disorders 2023; 7(2): 027 doi: 10.29328/journal.jnnd.1001078
|
2 |
Yixiao Dong, Kunkun Zhao, Xuemei Qin, Guanhua Du, Li Gao. The mechanisms of perineuronal net abnormalities in contributing aging and neurological diseases. Ageing Research Reviews 2023; 92: 102092 doi: 10.1016/j.arr.2023.102092
|
3 |
Liliana Dell’Osso, Chiara Bonelli, Benedetta Nardi, Federico Giovannoni, Cristiana Pronestì, Ivan Mirko Cremone, Giulia Amatori, Stefano Pini, Barbara Carpita. Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug. Brain Sciences 2024; 14(1): 103 doi: 10.3390/brainsci14010103
|
4 |
Joseph H. Friedman. Brief commentary: Under-recognition of underuse of clozapine in treating psychotic symptoms in Parkinson's disease. Schizophrenia Research 2023; doi: 10.1016/j.schres.2023.10.028
|